Showing results (2481-2490 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|February 15, 2022
Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in MexicoDaniel De-la-Rosa-Martinez, Mercedes Aranda-Audelo, Alexandra Martin-Onraet, et al.Cancer Medicine|February 18, 2022
Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based studyLin Liu, Jinglan Zhu, Yun TianCancer Medicine|October 6, 2021
Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomasLiguo Ye, Yang Xu, Long Wang, et al.Cancer Medicine|October 6, 2021
Possibility of brigatinib-based therapy, or chemotherapy plus anti-angiogenic treatment after resistance of osimertinib harboring EGFR T790M-cis-C797S mutations in lung adenocarcinoma patientsYaning Yang, Haiyan Xu, Li Ma, et al.Cancer Medicine|October 6, 2021
Prognostic implication of PD-L1 polymorphisms in non-small cell lung cancer treated with radiotherapyMin Kyu Kang, Shin Yup Lee, Jin Eun Choi, et al.Cancer Medicine|October 7, 2021
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomasXing Jin, Yuansheng Zheng, Zhencong Chen, et al.Cancer Medicine|February 7, 2022
Referral process to further evaluate poor sleep in breast cancer survivorsJulie L Otte, Yelena Chernyak, Shelley A Johns, et al.Cancer Medicine|February 7, 2022
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysisSteven Ades, Bhargavi Pulluri, Chris E Holmes, et al.Cancer Medicine|February 8, 2022
IL-34 in hepatoblastoma cells potentially promote tumor progression via autocrine and paracrine mechanismsTomoaki Irie, Daiki Yoshii, Yoshihiro Komohara, et al.Cancer Medicine|February 2, 2022
SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroupsBaoping Guo, Yujie Huang, Ying Duan, et al.Pageof 934